BTZ attenuates hypoxia‐induced PASMCs proliferation by restoring mitofusin‐2 expression, and inhibits right ventricular hypertrophy and pulmonary vascular remodeling both in hypoxia‐ and monocrotaline‐induced PAH animal models.2, 19. Here, CASC3 is linked to pulmonary arterial hypertension.